This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Zealand Pharma A/s. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Alistair Vincent Gordon Edwards: Innovator in GLP-1/GLP-2 Dual Agonists
Introduction
Alistair Vincent Gordon Edwards is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GLP-1 and GLP-2 receptors. With a total of 4 patents to his name, Edwards is recognized for his innovative approaches to treating metabolic dysfunction and intestinal damage.
Latest Patents
Edwards' latest patents include groundbreaking work on acylated GLP-1/GLP-2 dual agonists. These compounds exhibit agonist activity at both the GLP-1 and GLP-2 receptors. The pharmaceutical compositions he has developed can be utilized in the prophylaxis or treatment of intestinal damage and dysfunction, as well as in the regulation of body weight and metabolic dysfunction. His inventions represent a significant advancement in therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout his career, Alistair Edwards has been associated with Zealand Pharma A/S, where he has played a pivotal role in research and development. His work has not only contributed to the scientific community but has also paved the way for new treatment modalities in the pharmaceutical industry. His dedication to innovation is evident in the patents he has secured, which reflect his commitment to improving patient outcomes.
Collaborations
Edwards has collaborated with esteemed colleagues such as Bjarne Due Larsen and Lise Giehm. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and development at Zealand Pharma A/S.
Conclusion
Alistair Vincent Gordon Edwards stands out as a prominent inventor in the pharmaceutical field, particularly for his work on GLP-1/GLP-2 dual agonists. His contributions have the potential to significantly impact the treatment of metabolic and intestinal disorders. Through his innovative spirit and collaborative efforts, Edwards continues to advance the frontiers of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile